MAPK inhibition and growth hormone: a promising therapy in XLH
Publication date: | 2019 |
Publisher version: | http://dx.doi.org/10.1096/fj.201802007R |
Citación: | FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(7), p. 8349-8362 (2019); doi:10.1096/fj.201802007R |
Descripción física: | p. 8349-8362 |
ISSN: | 1530-6860 |
Patrocinado por: |
This study was supported by Fundación Nutrición y Crecimiento, Grants PI12/00987 (National Plan I + D + I2008–2011), PI15/02122 (Plan Estatal I + D + I 2013–2016), and PI18/01757 (Plan Estatal I + D + I 2017–2020) from the Instituto de Salud Carlos III (Madrid, Spain), and Fondo Europeo de Desarrollo Regional (FEDER). The authors declare no conflicts of interest. |
Id. Proyecto: |
ISCIII/FEDER/PI12/00987 ISCIII/FEDER/PI15/02122 ISCIII/FEDER/PI18/01757 |
Collections
- Artículos [27579]